Open AccessRetraction: Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies
Author(s) -
PLOS ONE Editors
Publication year - 2019
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0214006
Subject(s) - in vivo , in vitro , vimentin , cancer research , cancer , chemistry , biology , microbiology and biotechnology , medicine , pathology , biochemistry , immunohistochemistry , genetics